Join Drs Nihar Desai, Ankeet Bhatt, and Tariq Ahmad as they discuss implementation science and the management of cardiorenal metabolic syndrome.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999847. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association https://pubmed.ncbi.nlm.nih.gov/37807924/

A Global Health Tidal Wave? Cardiorenal Metabolic Syndrome https://www.medscape.com/viewarticle/999839

Social Determinants of Health in Cardiorenal Conditions https://www.medscape.com/viewarticle/999840

Implementation Science to Achieve Equity in Heart Failure Care: A Scientific Statement From the American Heart Association https://pubmed.ncbi.nlm.nih.gov/38567497/

Epidemiology of Chronic Kidney Disease: An Update 2022 https://pubmed.ncbi.nlm.nih.gov/35529086/

Inpatient Use of Guideline-Directed Medical Therapy During Heart Failure Hospitalizations Among Community-Based Health Systems https://pubmed.ncbi.nlm.nih.gov/39269395/

The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure With Reduced Ejection Fraction https://pubmed.ncbi.nlm.nih.gov/34950508/

The Inflation Reduction Act and Patient Costs for Drugs to Treat Heart Failure https://pubmed.ncbi.nlm.nih.gov/39470641/

The Inflation Reduction Act: How Will Medicare Negotiating Drug Prices Impact Patients With Heart Disease? https://pubmed.ncbi.nlm.nih.gov/37097432/

Evaluating Digital Technologies for Implementation Science https://pubmed.ncbi.nlm.nih.gov/35995390/

Join Drs Nihar Desai and Pam Taub as they discuss the nuances involved in understanding and managing triglycerides and HDL for cardiorenal metabolic syndrome.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999846. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A State-of-the-Art Review https://pubmed.ncbi.nlm.nih.gov/38103820/

The Association Between Triglycerides and Incident Cardiovascular Disease: What Is "Optimal"? https://pubmed.ncbi.nlm.nih.gov/32571728/

Helsinki Heart Study: Primary-Prevention Trial With Gemfibrozil in Middle-Aged Men With Dyslipidemia. Safety of Treatment, Changes in Risk Factors, and Incidence of Coronary Heart Disease https://pubmed.ncbi.nlm.nih.gov/3313041/

Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/20228404/

Triglyceride Lowering With Pemafibrate to Reduce Cardiovascular Risk https://pubmed.ncbi.nlm.nih.gov/36342113/

Apolipoprotein B https://emedicine.medscape.com/article/2087335-overview

Cardiovascular Risk Reduction With Icosapent Ethyl for Hypertriglyceridemia https://pubmed.ncbi.nlm.nih.gov/30415628/

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/33190147/

Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia https://pubmed.ncbi.nlm.nih.gov/38804517/

PCSK9 Inhibitors https://www.ncbi.nlm.nih.gov/books/NBK448100/

2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee https://pubmed.ncbi.nlm.nih.gov/34332805/

Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial https://pubmed.ncbi.nlm.nih.gov/39221651/

Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association https://pubmed.ncbi.nlm.nih.gov/37807924/

Join Drs Nihar Desai and Neda Rasouli as they discuss the evolution of obesity treatment over the past two decades, including the latest novel therapies.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999845. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A State-of-the-Art Review https://pubmed.ncbi.nlm.nih.gov/38103820/

Obesity https://emedicine.medscape.com/article/123702-overview

A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association https://pubmed.ncbi.nlm.nih.gov/37807920/

Obesity and Severe Obesity Prevalence in Adults: United States, August 2021–August 2023 https://www.cdc.gov/nchs/products/databriefs/db508.htm

Physiology, Obesity Neurohormonal Appetite and Satiety Control https://www.ncbi.nlm.nih.gov/books/NBK555906/

Melanocortin-4 Receptor Complexity in Energy Homeostasis, Obesity and Drug Development Strategies https://pubmed.ncbi.nlm.nih.gov/34882941/

Bariatric Surgery https://emedicine.medscape.com/article/197081-overview

The Effects of Bariatric Surgery on Cardiovascular Outcomes and Cardiovascular Mortality: A Systematic Review and Meta-Analysis https://pubmed.ncbi.nlm.nih.gov/36909063/

Semaglutide and Cardiovascular Outcomes in Obesity Without Diabetes https://pubmed.ncbi.nlm.nih.gov/37952131/

Comparison of Tirzepatide and Dulaglutide on Major Adverse Cardiovascular Events in Participants With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: SURPASS-CVOT Design and Baseline Characteristics https://pubmed.ncbi.nlm.nih.gov/37758044/

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity (SURMOUNT-MMO) https://clinicaltrials.gov/study/NCT05556512

Effects of Semaglutide on Chronic Kidney Disease in Patients With Type 2 Diabetes https://pubmed.ncbi.nlm.nih.gov/38785209/